These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 36749506)

  • 1. A Comparative Trial of Improving Care for Underserved Asian Americans Infected with Hepatitis B Virus.
    Ma GX; Zhu L; Tan Y; Zhai S; Ma X; Ogunwobi OO; Yang WJ; Ting T; Kim S; Wang MQ
    Dig Dis Sci; 2023 Jun; 68(6):2333-2343. PubMed ID: 36749506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a liver cancer education program on hepatitis B screening among Asian Americans in the Baltimore-Washington metropolitan area, 2009-2010.
    Juon HS; Lee S; Strong C; Rimal R; Kirk GD; Bowie J
    Prev Chronic Dis; 2014 Feb; 11():130258. PubMed ID: 24503341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial Disparities in Treatment Initiation and Outcomes of Chronic Hepatitis B Virus Infection in North America.
    Khalili M; Leonard KR; Ghany MG; Hassan M; Roberts LR; Sterling RK; Belle SH; Lok AS;
    JAMA Netw Open; 2023 Apr; 6(4):e237018. PubMed ID: 37036707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving Long-Term Adherence to Monitoring/Treatment in Underserved Asian Americans with Chronic Hepatitis B (CHB) through a Multicomponent Culturally Tailored Intervention: A Randomized Controlled Trial.
    Ma GX; Zhu L; Lu W; Handorf E; Tan Y; Yeh MC; Johnson C; Guerrier G; Nguyen MT
    Healthcare (Basel); 2022 Oct; 10(10):. PubMed ID: 36292391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
    Kim GA; Lim YS; Han S; Choi J; Shim JH; Kim KM; Lee HC; Lee YS
    Gut; 2018 May; 67(5):945-952. PubMed ID: 29055908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication.
    Jiang SW; Lian X; Hu AR; Lu JL; He ZY; Shi XJ; Zhu DD; Wang ZY; Huang GC
    World J Gastroenterol; 2023 Apr; 29(16):2479-2494. PubMed ID: 37179582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance for hepatocellular carcinoma in people of African ancestry with HIV and Hepatitis B.
    Patel N; Post FA
    Int J STD AIDS; 2022 Feb; 33(2):202-204. PubMed ID: 34546112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The risk of hepatocellular carcinoma among chronic hepatitis B virus-infected patients outside current treatment criteria.
    Sinn DH; Kim SE; Kim BK; Kim JH; Choi MS
    J Viral Hepat; 2019 Dec; 26(12):1465-1472. PubMed ID: 31332935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of development of hepatocellular carcinoma in Japanese patients infected with hepatitis B virus is equivalent between genotype B and C in long term.
    Haga H; Saito T; Okumoto K; Tomita K; Katsumi T; Mizuno K; Nishina T; Watanabe H; Ueno Y
    J Viral Hepat; 2019 Jul; 26(7):866-872. PubMed ID: 30924226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B) score in classifying treatment eligibility under 2012 Asian Pacific Association for the Study of the Liver (APASL) guideline for chronic hepatitis B patients.
    Chen TM; Chang CC; Huang PT; Wen CF; Lin CC
    Aliment Pharmacol Ther; 2013 Jan; 37(2):243-51. PubMed ID: 23171385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-World Effectiveness From the Asia Pacific Rim Liver Consortium for HBV Risk Score for the Prediction of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated With Oral Antiviral Therapy.
    Yang HI; Yeh ML; Wong GL; Peng CY; Chen CH; Trinh HN; Cheung KS; Xie Q; Su TH; Kozuka R; Lee DH; Ogawa E; Zhao C; Ning HB; Huang R; Li J; Zhang JQ; Ide T; Xing H; Iwane S; Takahashi H; Wong C; Wong C; Lin CH; Hoang J; Le A; Henry L; Toyoda H; Ueno Y; Gane EJ; Eguchi Y; Kurosaki M; Wu C; Liu C; Shang J; Furusyo N; Enomoto M; Kao JH; Yuen MF; Yu ML; Nguyen MH
    J Infect Dis; 2020 Jan; 221(3):389-399. PubMed ID: 31550363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural History of Chronic Hepatitis B Virus Infection in Ahvaz City, Iran.
    Makvandi M; Soleimani Jelodar R; Samarbafzadeh A; Neisi N; Sharifi Z; Gholampour A; Masjedizadeh A; Shayesteh A
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2125-2129. PubMed ID: 30139211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid Alanine Aminotransferase Normalization with Entecavir and Hepatocellular Carcinoma in Hepatitis B Virus-Associated Cirrhosis.
    Kim EJ; Yeon JE; Kwon OS; Lee HN; Shin SK; Kang SH; Byun KS; Kim JH; Kwon SY; Suh SJ; Yim HJ; Kim YS; Kim JH
    Dig Dis Sci; 2017 Mar; 62(3):808-816. PubMed ID: 28035553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy.
    Kim JH; Kim YD; Lee M; Jun BG; Kim TS; Suk KT; Kang SH; Kim MY; Cheon GJ; Kim DJ; Baik SK; Choi DH
    J Hepatol; 2018 Nov; 69(5):1066-1073. PubMed ID: 30075230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening.
    Robotin MC; Kansil M; Howard K; George J; Tipper S; Dore GJ; Levy M; Penman AG
    J Hepatol; 2009 May; 50(5):990-8. PubMed ID: 19303657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma.
    Chu CM
    J Gastroenterol Hepatol; 2000 May; 15 Suppl():E25-30. PubMed ID: 10921378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: Association between hepatitis B virus preS mutation and hepatocellular carcinoma risk.
    Wungu CDK; Ariyanto FC; Prabowo GI; Soetjipto S; Handajani R
    J Viral Hepat; 2021 Jan; 28(1):61-71. PubMed ID: 32896077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus.
    Kramer JR; Richardson PA; Kim H; Hsu YC; Kanwal F; El-Serag HB
    Clin Gastroenterol Hepatol; 2023 Apr; 21(4):1111-1113.e3. PubMed ID: 35276326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a community-based participatory and multilevel intervention to enhance hepatitis B virus screening and vaccination in underserved Korean Americans.
    Ma GX; Lee MM; Tan Y; Hanlon AL; Feng Z; Shireman TI; Rhee J; Wei Z; Wong F; Koh HS; Kim C; York W
    Cancer; 2018 Mar; 124(5):973-982. PubMed ID: 29131316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction models of long-term cirrhosis and hepatocellular carcinoma risk in chronic hepatitis B patients: risk scores integrating host and virus profiles.
    Lee MH; Yang HI; Liu J; Batrla-Utermann R; Jen CL; Iloeje UH; Lu SN; You SL; Wang LY; Chen CJ;
    Hepatology; 2013 Aug; 58(2):546-54. PubMed ID: 23504622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.